in India

Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25

170 Views

Biocon on Thursday said its board has approved to acquire 1.5% equity share capital for Rs 550 crore in Biocon Biologics, from one of its existing investors who decided to exercise the liquidity option, in an all cash deal.

Post this purchase, Biocon’s stake in Biocon Biologics will be 90.2%.

The…

Read More

What do you think?

0 Points
Upvote Downvote

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Ahead of Market: 10 things that will decide stock market action on Friday

Buy, Sell Or Hold: HAL, Axis Bank, Adani Power, LIC, KPIT Tech — Ask Profit